The generation of immune responses against most foreign pathogens or host-derived cancer cells is critically dependent on an initial phase of T-cell activation and proliferation. Activation of T cells occurs because the TCR is able to bind antigenic peptides complexed with major histocompatibility complex-encoded molecules, and to relay this extracellular stimulus to the intracellular signaling machinery. Signal initiation from the ligand-bound TCR involves the sequential activation of Src family (Lck,Fyn) and Syk family (ZAP-70) protein tyrosine kinases (PTKs). These TCR-regulation PTKs, in tum, catalyze phosphorylation events leading to the activation of phospholipase PLC-gamma-l, Ras, and phosphatidylinositol-3 kinase (PI-3K). In spite of the impressive advances in our understanding of TCR function in recent years, the mechanism by which this receptor couples to downstream signaling proteins, and the relative contributions of these proteins to the T-cell activation program, are only partially understood. To further define the process of TCR-mediated signal transduction, Dr. Abraham's group has created a novel set of cellular and molecular reagents that will allow the application of powerful genetic approaches to analyses of several key components of the post-receptor signaling machinery. The human T-leukemic cell line, Jurkat, was chosen as a well-established base model system for the proposed studies. The principal readout for TCR signaling function will be a prototypical nuclear response to TCR engagement, i.e., interleukin-2 (IL-2) gene expression.
The specific aims of the proposed project are: (1) To study the mechanism of ZAP-70 activation and the roles of this PTK in TCR signaling using a ZAP-70-negative Jurkat mutant as the cellular model system. (2) To define the mechanism of PLC-gamma-l activation by the TCR, and to determine the contributions of various PLC-gamma-l subdomains to the signaling functions of this enzyme during T-cell activation. (3) To examine the roles of PLC-gamma-l,Ras,and PI-3K in IL-2 gene transcription using a virus-derived oncoprotein as a polyfunctional signal transducer in T cells.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Schools of Medicine
United States
Zip Code
Williams, B L; Irvin, B J; Sutor, S L et al. (1999) Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-gamma1 and Ras activation. EMBO J 18:1832-44
Binstadt, B A; Brumbaugh, K M; Dick, C J et al. (1996) Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 5:629-38
Karnitz, L M; Sutor, S L; Abraham, R T (1994) The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line. J Exp Med 179:1799-808
Bonnema, J D; Karnitz, L M; Schoon, R A et al. (1994) Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J Exp Med 180:1427-35
Bonnema, J D; Rivlin, K A; Ting, A T et al. (1994) Cytokine-enhanced NK cell-mediated cytotoxicity. Positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exocytosis. J Immunol 152:2098-104
Secrist, J P; Burns, L A; Karnitz, L et al. (1993) Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J Biol Chem 268:5886-93
Burns, L A; Karnitz, L M; Sutor, S L et al. (1993) Interleukin-2-induced tyrosine phosphorylation of p52shc in T lymphocytes. J Biol Chem 268:17659-61
Ting, A T; Karnitz, L M; Schoon, R A et al. (1992) Fc gamma receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-gamma 1 and PLC-gamma 2 in natural killer cells. J Exp Med 176:1751-5